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Abstract
Introduction—Recent epidemiologic studies have shown that nonmedical use of prescription 
opioids (NMUPO) and major depression frequently co-occur. Comorbid forms of drug use and 
mental illness such as NMUPO and depression pose a greater disease burden than either condition 
alone. However, sociodemographic and substance use differences between individuals with either 
NMUPO or depression and those with comorbid conditions have not yet been fully investigated.
Methods—Data came from the 2011 and 2012 National Survey on Drug Use and Health 
(NSDUH). Adolescents and adults were examined independently because of differences in 
screening for major depressive episodes (MDE). Weighted multinomial logistic regression 
investigated differences between persons with either past-year NMUPO (4.0%) or MDE (5.5%) 
and those with comorbid NMUPO and MDE (0.6%), compared to persons with neither condition.
Results—Females were more likely than males to report either MDE-alone and comorbid 
NMUPO and MDE, whereas adult men were marginally more likely to report NMUPO-alone (not 
significant among adolescents). Polydrug use and alcohol use disorders were more pronounced 
among those with comorbid NMUPO and MDE than persons with either NMUPO-alone or MDE-
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alone. Persons with independent and comorbid NMUPO and MDE were more likely to report 
lower income and unemployment versus employment.
Conclusions—This study found that independent and comorbid NMUPO and MDE were 
disproportionately clustered with burdens of lower socioeconomic position, suggesting that a 
population-based approach to address NMUPO would target these social determinants of health, 
whereas a highrisk approach to prevention should be tailored to females experiencing MDE 
symptoms and polydrug users.
Keywords
addiction; illegal drug use; major depressive disorder; nonmedical use of prescription opioids; 
polydrug use
1. INTRODUCTION
Recent epidemiologic studies have shown that nonmedical use of prescription opioids 
(NMUPO) and major depression frequently co-occur (Becker et al., 2008; Goldner et al., 
2014; Martins et al., 2012). Comorbid forms of drug use and mental illness such as NMUPO 
and depression pose a greater disease burden than either condition alone, as such cases are 
more likely to experience more severe psychiatric symptoms (Kessler, 2004), 
rehospitalization (Appleby et al., 2001), incarceration (Hawthorne et al., 2012), and suicidal 
behaviors (Effinger and Stewart, 2012). Although nonmedical users of prescription opioids 
share many sociodemographic and behavioral characteristics with those who experience 
major depression (younger age, lower annual household income, and other substance use 
disorders, for example; Becker et al., 2008; Martins et al., 2012), these populations differ on 
other factors (sex, for example; Martins et al., 2012). The identification of characteristics 
that are specific to cases of comorbid NMUPO and major depressive episodes (MDE) can 
inform more effective intervention efforts tailored to this high-risk group. However, to our 
knowledge, no study has investigated the similarities and differences of populations who 
report NMUPO in the presences or absence of major depression.
Major depressive episodes and NMUPO are independently related to several of the same 
sociodemographic and substance use behaviors, including: age (Becker et al., 2008; Pratt 
and Brody, 2014; Wu et al., 2010), sex (Becker et al., 2008; Pratt and Brody, 2014; Wu et 
al., 2010), marital status (Becker et al., 2008; Riolo et al., 2005; Wu et al., 2010), and legal 
and illegal substance use (Becker et al., 2008). Although these risk factors are largely similar 
in the direction and magnitude of association with each MDE and NMUPO, certain risk 
factors differ. For example, whereas men are more likely than women to report NMUPO 
(Becker et al., 2008), women are more likely to have MDE (Hasin et al., 2005). Empirically 
it is very difficult to disentangle these various risk factors for MDE alone, NMUPO alone, 
and comorbid MDE and NMUPO. However, a study can estimate the relative frequency of 
differential factors to investigate the population profiles of persons with independent and 
comorbid NMUPO and MDE.
In the current study, we analyzed data from a nationally representative sample of the general 
U.S. population to identify similarities and differences among these populations that may 
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inform more tailored efforts to reduce NMUPO and related harm. Since MDE and NMUPO 
have similar risk factors—such that age, sex, marital status, education, and substance use are 
associated with major depression (Pratt and Brody, 2014; Riolo et al., 2005) and also 
NMUPO (Becker et al., 2008; Wu et al., 2010), we focused our investigation on factors 
previously shown to be related to both NMUPO and MDE. As such, if evidence suggests 
that sociodemographic and substance use factors are similar among persons reporting 
NMUPO-alone and those with comorbid NMUPO and MDE, then more global interventions 
should be implemented to reduce both NMUPO and MDE. Whereas, the identification of 
distinct associated factors for independent and comorbid NMUPO and MDE, suggests that 
intervention efforts should be more tailored to identify those at the highest risk.
2. METHODS
2.1. Sample
We used data from the National Survey of Drug Use and Health (NSDUH), conducted in 
2011 and 2012. As described in more detail elsewhere (SAMHSA, 2013, 2012), the NSDUH 
is an ongoing annual national survey that assesses tobacco use, alcohol use and disorders, 
illicit drug use and disorder, and mental health symptoms in the US. The NSDUH 
respondents are selected from an independent multistage area probability sample of each of 
the 50 States and District of Columbia, yielding a nationally-representative sample of the 
noninstituionalized US citizen population aged 12 years and older. After selection of 
potential study respondents, study trained interviewers explained all study procedures to 
respondents, including assurances to strict confidentiality of personal responses, obtained 
informed consent, and administered interviews using computer-assisted personal 
interviewing (CAPI) and audio computer-assisted self-interviewing (ACASI). The combined 
use of CAPI with ACASI are employed to increase the validity of self-reported data by 
providing a confidential means for the interviewees to respond to sensitive questions about 
illicit drug use and other behaviors (Biondo and Chilcoat, 2014; SAMHSA 2012, 2013a).
Starting in 2011, post-stratification weights were applied to adjust the NSDUH data to the 
distribution of the US population projections from the 2010 census. Therefore, we restricted 
our analysis to data from the 2011 (n = 58,397) and 2012 (n = 55,268) NSDUH public use 
files to assure the samples were weighted to comparable population estimates and to ensure 
that concatenating the data would not compromise its integrity. Since the NSDUH employs 
separate depression screeners for adolescents (12-17 years) and adults (18+years), we 
stratified the total sample into two groups at 18 years (i.e., 12-17, 18+). The final datasets 
included survey responses from 36,663 adolescent and 77,002 adult respondents. The 
weighted response rates for 2011 and 2012 were 73% and 74% respectively.
2.2. Measures
2.2.1 Past-year nonmedical use of prescription opioids (NMUPO)—Past-year 
NMUPO was determined through a three-stage process. First, the respondents were asked 
whether they have ever used “any form of prescription pain reliever that were not prescribed 
for you or that you took only for the experience or feeling they caused.” Second, 
respondents were presented with pictures and names of different types of prescription 
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opioids (e.g., Darvocet, Percocet, Vicodin) and asked if they had ever used them 
nonmedically (e.g., “Have you ever, even once, used Darvocet, Darvon, or Tylenol with 
codeine that was not prescribed for you or that you took only for the experience or feeling it 
caused?”; SAMHSA 2012, 2013a). Finally, respondents were asked: “How long has it been 
since you last used any prescription pain reliever that was not prescribed for you or that you 
took only for the experience or feeling it caused?” Respondents endorsing use during the 
preceding 12 months were classified as past-year nonmedical prescription opioid users.
2.2.2 Past-year major depressive episode (MDE)—We defined cases of major 
depressive episode using the Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition (DSMIV; American Psychiatric Association, 2000) criteria. The adolescent and 
adult MDE screeners was derived from the National Comorbidity Survey-Adolescent and 
National Comorbidity Survey-Replication (SAMHSA 2012, 2013a) respectively; 
respondents who endorsed experiencing five or more of the nine DSM-IV MDE symptoms, 
with at least one of these symptoms being either anhedonia (“little interest or pleasure in 
doing things”) or depressed mood (“feeling down, depressed, or hopeless”), for more than 
half the days over the course of a two-week period during their worst or more recent period 
in their lifetime, were determined to screen positive for MDE. Participants endorsing that at 
least a two-week period of the depressive symptoms occurred during the previous year 
determined the presence of a MDE in the past 12 months. In the survey, respondents 
endorsing MDE that was related to substance use, grief, or physical comorbidity respondents 
were still considered as having a past-year MDE (SAMHSA 2012, 2013a). Finally, we 
created a four-class nominal variable for past-year NMUPO and MDE, including: neither 
NMUPO nor MDE, NMUPO without MDE (NMUPO-alone), MDE without NMUPO 
(MDE-alone), and NMUPO with MDE (NMUPO+MDE).
2.2.3 Socio-demographic variables—We considered 10 potential independent 
variables of interest, including: self-reported sociodemographics (7 items), drug use 
characteristics (2 items), and population characteristics (1 item). Adolescent and adult 
sociodemographics included age at time of interview ([adolescents: 12-13 as reference, 
14-15, and 16-17] and [adults: 18-25 and 26-34, 35 years or older as reference]), sex (male, 
female as reference), race/ethnicity (non-Hispanic white as reference, non-Hispanic black, 
non-Hispanic American Indian or Alaska Native [Native American], non-Hispanic Native 
Hawaiian or other Pacific Islander [Pacific Islander], non-Hispanic Asian, non-Hispanic two 
or more races, and Hispanic/Latino), and total annual family income in US dollars (0 to 19 
999, 20 000 to 39 999, and 40 000 to 74 000, 75 000 as reference). Additional adult 
sociodemographics included: education (less than high school and high school or equivalent, 
some college or more as reference), marital status (single and previously married [widowed, 
divorced, or separated], married as reference), and employment status (employed as 
reference; unemployed and other). Drug experience characteristics included past-year drug 
use other than NMUPO (yes/no) and alcohol use disorder (yes/no). To determine past-year 
drug use other than NMUPO, respondents indicated whether they used several types of 
illegal drugs during the previous 12 months (yes or no), including: cocaine, heroin, 
inhalants, marijuana, and other nonmedical prescription drug use (e.g., stimulants, sedatives, 
tranquilizers). We summed the number of listed illegal drugs endorsed by the respondent 
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and created a binary variable to indicate the presence (versus absence) of any past-year 
illegal drug use other than nonmedical prescription opiates. Respondents meeting criteria for 
past-year alcohol abuse or dependence were classified as having an alcohol use disorder. 
Finally, county status (large metro as reference; small metro and non-metro) was derived 
from the 2010 Census data (SAMHSA 2012, 2013a).
2.3 Statistical analysis
To investigate the population profiles of persons with independent and comorbid NMUPO 
and major depression, we defined four mutually exclusive sub-groups on the basis of 
whether respondents reported past-year (i) NMUPO but not MDE (NMUPO-alone); (ii) 
MDE but not NMUPO (MDE-alone); (iii) NMUPO and MDE symptoms (MDE+NMUPO); 
or (iv) neither NMUPO nor MDE. We then examined sociodemographic and substance use 
factors that distinguish comorbid MDE and NMUPO profiles from persons reporting 
NMUPO-alone or MDEalone in three phases. First, descriptive characteristics of the sample 
(i.e., prevalence and standard errors [SE]) were calculated. Cross-tabulations using chi-
squared Wald F tests were used to examine past-year prevalence estimates for NMUPO-
alone, MDE-alone, and NMUPO+MDE by covariates.
Second, we estimated unadjusted odds ratios (ORs) and 95% confidence intervals (CI) of 
each of the three categories of respondents (NMUPO-alone, MDE-alone, NMUPO+MDE) 
compared to the reference group without NMUPO or MDE. Multinomial logistic regression 
was used to examine the differences between the four categories of NMUPO and MDE with 
covariates.
Finally, we examined a multivariable multinomial logistic regression to estimate 
independent determinants (i.e., age, race/ethnicity, education, marital status, total family 
income, employment status, any past-year drug use, past-year alcohol use disorder) for 
NMUPO-alone, MDE-alone, and comorbid NMUPO and MDE groups in adults. Next, we 
estimated the same model, without employment and marital status, in the adolescent sample. 
Adjusted odds ratios (AOR) and 95% CIs were calculated. All data analysis was performed 
using SAS v 9.3 (SAS, Cary NC), and SUDAAN v 11 (Research triangle Institute, NC) was 
used to estimate standard errors using the Taylor series linearization method and to adjust 
for the effects of the weighting and clustering on the precision of estimates (Wolter, 1985).
3. RESULTS
3.1. Prevalence of past-year MDE and NMUPO (Figure 1)
Over twice the proportion of respondents reporting past-year NMUPO met criteria for 
comorbid MDE compared to persons not reporting NMUPO for both adolescents (19.9% 
versus 7.9%) and adults (15.2% versus 6.4%). Among adolescent and adult respondents, 
5.8% (SE=0.17) and 4.5% (SE=0.13) respectively reported any past-year NMUPO, while 
8.6% (SE=0.19) and 6.8% (SE=0.13) met criteria for past-year MDE. The overall 
prevalence of comorbid NMUPO and MDE was 1.2% (SE=0.08) and 0.7% (SE=0.04) 
among adolescent and adult respondents, respectively.
Fink et al. Page 5









3.2. Sociodemographics of independent and comorbid NMUPO and MDE (Table 1)
All bivariate tests of differences were statistically significant at p<0.05 among both 
adolescents and adults. As anticipated, a higher proportion of males (compared to females) 
reported NMUPO-alone, whereas about twice the proportion of women compared to men 
reported both MDE-alone and comorbid NMUPO+MDE. Among adults, NMUPO+MDE 
was significantly more common among unemployed persons and those reporting lower 
annual family income. Respondents endorsing any drug use other than NMUPO and meeting 
criteria for an alcohol use disorder were observed to have the largest differences in 
prevalence of sub-group membership; specifically, the frequency of alcohol use disorder 
was about 3 times higher among those with MDE-alone compared to those with neither 
MDE nor NMUPO and over 5 times higher among those with either NMUPO-alone or 
NMUPO+MDE.
3.3. Correlates of independent and comorbid NMUPO and MDE (Table 2)
Table 2 shows the multivariable multinomial logistic regression results of sociodemographic 
and behavioral characteristics that compare NMUPO-alone, MDE-alone, and NMUPO
+MDE with those with neither NMUPO nor MDE. Columns 1-3 show the AOR for 
NMUPO and MDE in adolescents, adjusting for age, race/ethnicity, annual family income, 
drug use other than NMUPO, and alcohol use disorders, whereas columns 4-6 show the 
AOR for NMUPO and MDE in adults, adjusting for all the variables in the adolescent model 
and marital and employment status. Among both adolescents and adults, females were more 
likely than males to report MDE-alone (AOR=3.2 [adolescents]; AOR=1.9 [adults]) and 
NMUPO+MDE (AOR=3.7 [adolescents]; AOR=2.1 [adults]) than those without NMUPO or 
MDE. In addition, differences in MDE and NMUPO categories were observed across race/
ethnicity, marital status, income, and employment. Asians were about half as likely as Non-
Hispanic whites to report NMUPO-alone and comorbid NMUPO+MDE, and Non-Hispanic 
blacks were less likely than whites to report MDE-alone (adolescents and adults) and 
comorbid NMUPO+MDE (adults only). Among adults, never married respondents were 
more likely than married respondents to report NMUPO-alone (AOR=1.6; 95% CI, 1.3-1.9), 
MDE-alone (AOR=1.3; 95% CI, 1.1-1.5), and NMUPO+MDE (AOR=1.8; 95% CI, 1.1-2.9), 
whereas previously married respondents were more likely to report MDE-alone (AOR=1.5; 
95% CI, 1.3-1.7) and NMUPO+MDE (AOR=2.0; 95% CI, 1.4-3.0). Finally, unemployed 
and lower income respondents were more likely to report MDE and NMUPO alone, and 
comorbid NMUPO+MDE than their respective categories.
Past-year drug use other than NMUPO and alcohol use disorder were the strongest factors 
associated with NMUPO-alone, MDE-alone, and NMUPO+MDE. However, the association 
between drug use other than NMUPO and alcohol use disorder with NMUPO+MDE was 
substantially stronger than the relationship between these factors with NMUPO or MDE 
alone, such that adult respondents that endorsed other drug use other than NMUPO and 
alcohol use disorder were respectively 15.9 and 4.5 times more likely to have NMUPO
+MDE, 6.6 and 3.0 times more likely to report NMUPO-alone, and 2.5 and 2.7 times more 
likely to report MDE-alone compared to neither NMUPO nor MDE. Moreover, respondents 
endorsing drug use other than NMUPO and alcohol use disorder were significantly more 
likely to report NMUPO-alone and NMUPO+MDE, but not MDE-alone.
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Using data from a nationally representative sample of adolescents and adults we found that 
sociodemographic and substance use characteristics were different for persons who reported 
either past-year NMUPO or MDE alone or comorbid NMUPO and MDE. Notably, 
compared to persons with neither condition, those with comorbid NMUPO and MDE were 
more likely to be female, of low annual income, not currently married, and to report an 
alcohol use disorder or other drug use. This suggests that intervention efforts to reduce the 
disease burden associated with comorbid NMUPO and MDE should focus on those at the 
highest risk, particularly females with major depression and persons with alcohol use 
disorder or illicit drug use.
Our results that women were more likely than men to screen positive for MDE, with or 
without past-year NMUPO, is not surprising given prior studies demonstrating that women 
are at an increased risk for both depression alone (Kendler et al., 2005; Piccinelli and 
Wilkinson, 2000) and comorbid substance use and depression (Chen et al., 2011; Kessler et 
al., 1997). However, underlying major depression may account for the previously 
inconsistent relationship between NMUPO and sex (Becker et al., 2008; Wu et al., 2008). 
For example, Becker et al. (2008) showed males were significantly more likely than females 
to report NMUPO, but this relationship became insignificant when adjusting for several 
covariates, one of which was depression. Thus, females with major depression may be more 
likely than males to use psychoactive substances, such as prescription opioids, which 
confounds the unadjusted relationship between sex and NMUPO.
Consistent with previous survey results, we found that the burden of NMUPO (Becker et al., 
2008; Huang et al., 2006; Wu et al., 2010) and MDE (Hasin et al., 2005; Kessler et al., 
2003) alone, and comorbid NMUPO and MDE (Schepis and Hakes, 2011), was greater in 
those with lower socioeconomic position (SEP), specifically lower household income and 
less employment. Decades of research have documented a higher burden of mental disorders 
among persons in lower SEP than among those in higher SEP (Johnson et al., 1999; Kessler 
et al., 1995). Two hypotheses have been proposed to explain this relationship between SEP 
and mental and substance use disorders, specifically social selection and social causation 
(Dohrenwend et al., 1992). Whereas the former explains that persons with mental disorders 
drift down the SES continuum (such that, the person’s disorder causes their low SES), the 
latter posits that those with low SES develop psychopathology in response to the adversity 
and trauma in their environment. Irrespective of the direction of causation, the general 
consensus in the literature is that multiple processes, rather than a single underlying 
mechanism, are likely to drive this association between SEP and comorbid substance use 
and psychiatric disorder. Taken together, these findings suggest that intervention efforts that 
act on the social determinants of health, such as income distribution and family 
fragmentation (Cerdá et al., 2013a), can have a crosscutting effect on both NMUPO and 
MDE.
Other drug use and alcohol use disorders were more strongly associated with comorbid 
MDE and NMUPO, followed in magnitude by NMUPO alone, as compared to those with 
neither condition. The high prevalence of polydrug use among persons with NMUPO 
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observed in this study is consistent with previous literature (Connor et al., 2014). One recent 
study used latent class analysis (LCA) to show three clusters of polydrug use; a limited-
range cluster (who use alcohol, tobacco, and marijuana), moderate-range cluster (who use 
amphetamines as well as drugs of the limited-range cluster), and an extended-range cluster 
(who use nonmedical prescription opioids and other illegal drugs; Connor et al., 2014). The 
combined evidence that NMUPO clusters in the most extended range of polydrug use and 
that the substantial majority of opioid related emergency department visits involve polydrug 
use (62%; CDC, 2010) and are among females (Cerdá et al., 2013c), suggests a confluence 
of factors that identify the potential high risk associated with comorbid NMUPO and MDE. 
In addition, psychiatric disorders, including major depression, are documented to increase 
the risk for substance abuse or dependence disorders among users (Martins and Gorelick, 
2011). Therefore, longitudinal research that assesses drug use trajectories among this high-
risk group will be particularly important to further inform population level interventions 
already enacted, such as the education of providers and patients about drug diversion (CDC, 
2012) and prescription drug monitoring programs (Davis et al., 2014).
4.1. Limitations
This study should be considered within the context of five primary limitations that are 
consistent with all large-scale epidemiologic surveys. First, past-year NMUPO and MDE 
symptoms were self-reported (i.e., not determined through clinical diagnosis by a healthcare 
professional) and could be subject to recall bias. However, studies have shown that survey 
methods used here produce good reliability and validity (SAMHSA, 2010). Second, 
exclusion of incarcerated, institutionalized, and homeless adults limits generalizability. 
These exclusion criteria of potentially high-risk groups (e.g., incarcerated adults) may 
underestimate the prevalence of NMUPO in the US. Third, respondents may have 
underreported NMUPO and MDE symptoms (Biondo and Chilcoat, 2014; Eaton et al., 
2000). However, methodological studies have documented the NSDUH had minimized this 
bias more effectively than other largescale epidemiologic surveys through the use of 
computer-assisted self-administered interviewing methods and visual aids (Biondo and 
Chilcoat, 2014; Harrison et al., 2007). Fourth, as our study is cross-sectional, we are unable 
to make any temporal claims about the associations between sociodemographic/behavioral 
characteristics and NMUPO and depression, nor explain the temporality between the onset 
of major depression and nonmedical use of prescription opioids. As there is substantial 
evidence for a bidirectional relationship between these conditions, future studies are needed 
to elucidate the causal partners of each major depression and NMUPO to explain the 
mechanisms that drive comorbidity. Finally, we did not consider statistical interaction in our 
model because without an explicit a priori hypothesis about potential interactions the 
increase in the potential for Type I error and the added complexity made this unfeasible. 
However, in the presence of interaction, an adjusted estimate provides the weighted average 
across levels of the interaction, which was of interest for our purposes. Nonetheless, futures 
studies that examine subgroup differences are recommended to improve prediction models.
4.2. Conclusions and clinical implications
Comorbid NMUPO and MDE is common, indicating that preventative education about the 
signs and symptoms of NMUPO combined with MDE are important for primary care and 
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specialists (such as, orthopaedists and rheumatologists) alike. These education efforts should 
include a push to increase screening for NMUPO and MDE among high-risk patients. Our 
analysis highlighted the complex interplay among sex, major depression, and NMUPO that 
has been previously underappreciated in studies. Specifically, we found that women are 
more likely than men to have major depression and comorbid NMUPO and major 
depression—a finding that has not been previously documented. In addition, we found that 
past-year illegal drug use other than NMUPO and alcohol use disorder were strongly 
associated with NMUPO-alone, MDE-alone, and, particularly, comorbid NMUPO and 
MDE. This finding highlights a need for interventions to target both high-risk polydrug 
users and population level interventions to ameliorate misuse of prescription opioids. 
Finally, we found that independent and comorbid NMUPO and MDE were 
disproportionately clustered with burdens of lower socioeconomic position (e.g., lower 
income, unemployment), suggesting that a population-based approach to address NMUPO 
in the U.S. would target these social determinants of health. Future longitudinal studies are 
needed to investigate the affect of depression on prescription opioid use trajectories, among 
both nonmedical and medical users.
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• We examined comorbid depression and nonmedical use of prescription opioids 
(NMUPO).
• Women were more likely than men to have depression alone, or with comorbid 
NMUPO.
• Polydrug use was particularly common in those with comorbid depression and 
NMUPO.
• Tailored interventions for females with depression and polydrug users are 
suggested.
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Past-year major depressive episode symptoms by nonmedical use of prescription opioid 
(NMUPO) in adolescents (12-17 years) and adults (18 years or more), 2011-2012a
a
 Source: National Survey on Drug Use and Health, 2011-2012. Percentages are weighted to 
be nationally representative.
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